Pancreatic Cancer Therapeutics Market Analysis, Patents, Designations, Collaborations, and Other Developments: Pharma Proff
May 27, 2019 01:30 ET
|
Prescient & Strategic Intelligence
NEW YORK, May 27, 2019 (GLOBE NEWSWIRE) -- According to a new research report “Pancreatic Cancer Therapeutics" by Pharma Proff, a brand of P&S Intelligence, pancreatic cancer currently exhibits...
Pancreatic Cancer Therapeutics in Major Developed Markets To Rise at a Moderate CAGR of 7.6% from $1.746bn in 2014 to $2.92bn in 2021 Says MarketResearchReports.Biz
January 04, 2016 01:06 ET
|
MarketResearchReports.Biz
Albany, NY, Jan. 04, 2016 (GLOBE NEWSWIRE) -- Pancreatic Cancer (PC) is a disease predominately of the elderly with ~75% of PC cases being diagnosed in patient’s over 75 years old. PC proliferates...